According to FutureWise analysis the market for minimally invasive glaucoma surgery (migs) devices in 2023 is US$ 0.72 billion, and is expected to reach US$ 8.01 billion by 2031 at a CAGR of 35.22%.
For the treatment of glaucoma patients, minimally invasive glaucoma surgery devices provide an ab interno technique that avoids medication and conjunctival invasion. Patients with mild-to-moderate glaucoma are treated with MIGS devices such as stents, shunts, micro implants, and others. Over the years, there has been a growing preference for MIGS devices over standard glaucoma surgical devices, as the former are both safer and more successful than the latter. Furthermore, market players' increased attention on the development of stents specifically for minimally invasive glaucoma procedures that can successfully reduce intraocular pressure (IOP) enhances market growth. Furthermore, the global growth of the minimally invasive glaucoma surgery (MIGS) devices market is fueled by an increase in the prevalence of glaucoma, a rise in the geriatric population susceptible to a variety of ocular illnesses, including glaucoma, and changes in demography.
The market is expected to rise due to an increase in the global elderly population, as well as an increase in the prevalence of glaucoma, a surge in demand for combined glaucoma and cataract procedures, and a shift in leading firms' attention to the development of MIGS stents. In addition, AbbVie purchased Allergan plc in 2019 for eye care products such as xen, durysta, ozurdex, and refresh/optive. With these significant improvements, regional players are aiming a foothold in the minimal invasive glaucoma surgery device market.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Minimally Invasive Glaucoma Surgery (MIGS) Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.